Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
Abstract Background Alterations in the composition of the fecal microbiota in children with juvenile idiopathic arthritis (JIA) have been observed in several studies, but it has not been determined whether the standard treatment for JIA changes the composition or function of the microbiota. The firs...
Saved in:
Main Authors: | Anders Öman (Author), Johan Dicksved (Author), Lars Engstrand (Author), Lillemor Berntson (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dynamics of concomitant therapy in children with juvenile idiopathic arthritis treated with etanercept and methotrexate
by: Ekaterina Alexeeva, et al.
Published: (2019) -
Evaluation of Efficacy and Safety of Etanercept and Etanercept + Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis without Systemic Manifestations
by: T. M. Bzarova, et al.
Published: (2016) -
Blood brain barrier permeability and astrocyte-derived extracellular vesicles in children with juvenile idiopathic arthritis: a cross-sectional study
by: Lillemor Berntson, et al.
Published: (2024) -
A pilot study of possible anti-inflammatory effects of the specific carbohydrate diet in children with juvenile idiopathic arthritis
by: Lillemor Berntson
Published: (2021) -
Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study
by: Tiina Levälampi, et al.
Published: (2023)